Asensus Surgical Inc. (AMEX:ASXC) saw an upside of 5.78% to close Tuesday at $1.83 after adding $0.1 on the day. The 5-day average trading volume is 2,135,720 shares of the company’s common stock. It has gained $1.8400 in the past week. An average of 3,567,970 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 3,805,806.
ASXC’s 1-month performance is -8.96% or -$0.2200 on its low of $1.6800 reached on 10/11/21. The company’s shares have touched a 52-week low of $0.35 and high of $6.95, with the stock’s rally to the 52-week high happening on 02/10/21. YTD, ASXC has achieved 192.80% or $1.2050. However, the current price is down -73.67%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Jun 09, 126 days have gone by since the last insider trading activity for Asensus Surgical Inc. (ASXC). Fernando Anthony C. J. (President and CEO) most recently sold 295,682 shares at $3.10 per share on Jun 09. This transaction cost the insider $916,613. President and CEO, Fernando Anthony C. J., sold 2,112 shares at a price of $3.51 on Jun 08.
Asensus Surgical Inc. (ASXC) has a trailing price-to-earnings (P/E) ratio of 26.30 for the broader industry and 32.19 for the sector.ASXC stock has a beta of 1.57. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 86.51 while the price-to-book (PB) in the most recent quarter is 2.18.
Asensus Surgical Inc.’s quick ratio for the period ended June 29 was 19.40, with the current ratio over the same period at 20.90 meaning that ASXC stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.00, while the total debt to equity was 0.00. In terms of profitability, the gross margin trailing 12 months is -46.40%. The trailing 12-month EBITDA margin is -1351.65%. The firm’s gross profit as reported stood at -$1.99 million against revenue of $3.17 million.
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected ASXC to announce -$0.06 per share in earnings in its latest quarter, but it posted -$0.06, representing a 0.00% surprise. EBITDA for the quarter stood at more than -$12.44 million. ASXC stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 16.44 million, with total debt at $4.33 million. Shareholders hold equity totaling $234.32 million
Let’s look briefly at Asensus Surgical Inc. (ASXC) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 50.07% to suggest the stock is trending Neutral, with historical volatility in this time period at 56.41%.
The stock’s 5-day moving average is $1.7560, reflecting a +5.78% or $0.1000 change from its current price. ASXC is currently trading -5.67% above its 20-day SMA, -14.08% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -23.11% and +220.60% respectively.
Stochastic %K and %D was 22.73% and 17.18% and the average true range (ATR) pointed at 0.1092. The RSI (14) points at 45.70%, while the 14-day stochastic is at 44.12% with the period’s ATR at 0.1191. The stock’s 9-day MACD Oscillator is pointing at -0.0078 and -0.0431 on the 14-day charts.
In the most recent analyst report for Asensus Surgical Inc. (AMEX: ASXC), H.C. Wainwright launched coverage with a Buy rating. Analysts offering their rating for ASXC stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate ASXC as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.
What is ASXC’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $4.00 and a high of $4.00, with their median price target at $4.00. Looking at these predictions, the average price target given by analysts is for Asensus Surgical Inc. (ASXC) stock is $4.00.